These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 21029856)

  • 1. Monocytes join the dendritic cell family.
    Sallusto F; Lanzavecchia A
    Cell; 2010 Oct; 143(3):339-40. PubMed ID: 21029856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD14 and CD83 from human neonatal antigen-presenting cells are inducible by commensal bacteria and suppress allergen-induced human neonatal Th2 differentiation.
    Lundell AC; Andersson K; Josefsson E; Steinkasserer A; Rudin A
    Infect Immun; 2007 Aug; 75(8):4097-104. PubMed ID: 17526743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
    Moll H; Flohé S; Röllinghoff M
    Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo.
    Rotta G; Edwards EW; Sangaletti S; Bennett C; Ronzoni S; Colombo MP; Steinman RM; Randolph GJ; Rescigno M
    J Exp Med; 2003 Oct; 198(8):1253-63. PubMed ID: 14568983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human rheumatoid synovial and normal blood dendritic cells as antigen presenting cell--comparison with autologous monocytes.
    Waalen K; Førre O; Teigland J; Natvig JB
    Clin Exp Immunol; 1987 Oct; 70(1):1-9. PubMed ID: 2826055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commensal oral bacteria antigens prime human dendritic cells to induce Th1, Th2 or Treg differentiation.
    Kopitar AN; Ihan Hren N; Ihan A
    Oral Microbiol Immunol; 2006 Feb; 21(1):1-5. PubMed ID: 16390334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Langerhans cell: from in vitro production to use in cellular immunotherapy].
    Schmitt D
    J Soc Biol; 2001; 195(1):69-74. PubMed ID: 11530504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The cow, the boy and the lymph node--immunological principles for vaccines].
    Munthe LA
    Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2532-7. PubMed ID: 17028635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells.
    Cools N; Ponsaerts P; Van Tendeloo VF; Berneman ZN
    J Leukoc Biol; 2007 Dec; 82(6):1365-74. PubMed ID: 17711977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial progenitor cells possess monocyte-like antigen-presenting and T-cell-co-stimulatory capacity.
    Raemer PC; Haemmerling S; Giese T; Canaday DH; Katus HA; Dengler TJ; Sivanandam VG
    Transplantation; 2009 Feb; 87(3):340-9. PubMed ID: 19202438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct ex vivo activation of T cells for analysis of dendritic cells antigen presentation.
    Belz GT
    Methods Mol Biol; 2010; 595():351-69. PubMed ID: 19941124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells as antigen presenting cells in vivo.
    Inaba K; Metlay JP; Crowley MT; Witmer-Pack M; Steinman RM
    Int Rev Immunol; 1990; 6(2-3):197-206. PubMed ID: 2152503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD2+/CD14+ monocytes rapidly differentiate into CD83+ dendritic cells.
    Di Pucchio T; Lapenta C; Santini SM; Logozzi M; Parlato S; Belardelli F
    Eur J Immunol; 2003 Feb; 33(2):358-67. PubMed ID: 12548567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Afferent lymph veiled cells prime CD4+ T cell responses in vivo.
    McKeever DJ; Awino E; Morrison WI
    Eur J Immunol; 1992 Dec; 22(12):3057-61. PubMed ID: 1359968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells and immune responses to orally administered antigens.
    Mowat AM
    Vaccine; 2005 Mar; 23(15):1797-9. PubMed ID: 15734044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell migration to peripheral lymph nodes.
    Martín-Fontecha A; Lanzavecchia A; Sallusto F
    Handb Exp Pharmacol; 2009; (188):31-49. PubMed ID: 19031020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting dendritic cells for priming cellular immune responses.
    Gogolák P; Réthi B; Hajas G; Rajnavölgyi E
    J Mol Recognit; 2003; 16(5):299-317. PubMed ID: 14523943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.